ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000260988.1	Nilotinib	Bladder urothelial carcinoma	0.003567822	Resistant
ENSG00000260988.1	Nilotinib	Stomach adenocarcinoma	0.040577306	Sensitive